Healthcare Social Media and Updates

Insulin Spikes Can Halt Ovulation and Fertility
SocialMar 14, 2026

Insulin Spikes Can Halt Ovulation and Fertility

Most women don't realize that blood sugar issues can shut down ovulation. When insulin stays elevated, it suppresses something called SHBG, which means too much free testosterone begins to circulate. That excess testosterone interferes with follicle development and can stop the...

By Preethi Kasireddy
Health Canada Cuts Alcohol Limit to Two Drinks Weekly
SocialMar 14, 2026

Health Canada Cuts Alcohol Limit to Two Drinks Weekly

Health Canada recommends limiting alcohol to just 2 drinks per week 🍷(In case you missed it, since 2023) https://t.co/44vxHDboSx https://t.co/hkhxyFe8fi

By David Barzilai, MD PhD
From Tin Hat to Systems‑Based Health Policy Insight
SocialMar 14, 2026

From Tin Hat to Systems‑Based Health Policy Insight

Sometimes I feel like a tin hat but I also studied in a field that focuses on the interconnected nature of systems and how these systems impact health And then I worked in policy, understanding how decisions are made about...

By Rhet Lage (public health advocate)
AI May Help Detect Rare, Often‑Missed Diagnoses
SocialMar 14, 2026

AI May Help Detect Rare, Often‑Missed Diagnoses

Nice piece @axios by @caitlinnowens on the use of AI by docs for diagnosis. She describes her mom's amyloid (rare & oft-missed multisystem illness) misdiagnosis. I'm not 100% sure AI would have helped, but it does have some unique skills...

By Robert (Bob) Wachter, MD
Google's AMIE Shows Promise, Still Needs Clinician Partner
SocialMar 14, 2026

Google's AMIE Shows Promise, Still Needs Clinician Partner

A great discussion by the brilliant @AdamRodmanMD on the new study of @Google 's AMIE (medical AI) tool, including the study's limitations. Bottom line is the tool's performance is impressive and getting better, but it's still best thought of as...

By Robert (Bob) Wachter, MD
Periods Can Take Years to Return After Long-Term Birth Control
SocialMar 14, 2026

Periods Can Take Years to Return After Long-Term Birth Control

When I came off birth control after 13 years, I expected my period to come back within a month or two. It took 3.5 years. Most doctors will tell you your cycle should return within 3 months. For some women...

By Preethi Kasireddy
Drug Patents: Near-Term Generic Threat, Mid-Term Safeguards, Tirzepat
SocialMar 14, 2026

Drug Patents: Near-Term Generic Threat, Mid-Term Safeguards, Tirzepat

AI: Short-Term Cliffs (0-3 years remaining): Drugs like sacubitril/valsartan, dapagliflozin, pembrolizumab, ocrelizumab, daratumumab, and apixaban face imminent generic/biosimilar pressure Mid-Term Protection (4-7 years): Risankizumab and dupilumab have solid runway, supported by ongoing label expansions. Long-Term (8+ years): Tirzepatide's robust patents position it...

By Peter Suzman
Judge Denies Epic's Dismissal Motion, Loss Expected
SocialMar 14, 2026

Judge Denies Epic's Dismissal Motion, Loss Expected

Another big Epic litigation update, as Judge Fillmore denied Epic's Motion to Dismiss in full in Texas v. Epic. It’s a loss, but somewhat of an expected one, as the state specific 91a pleading standard is a low bar. https://t.co/S9eI9qwFOV

By Brendan Keeler
Micro-Cages Enable Precise Manipulation of Cell Clusters
SocialMar 14, 2026

Micro-Cages Enable Precise Manipulation of Cell Clusters

These micro-cages are designed to hold and manipulate tiny cell clusters in miniaturized lab-on-a-chip devices. https://spectrum.ieee.org/lab-on-a-chip-grippers?share_id=9241061

By IEEE Spectrum Threads
First Human Age‑Reversal Trial Targets Whole‑Body Reset
SocialMar 14, 2026

First Human Age‑Reversal Trial Targets Whole‑Body Reset

The first human age-reversal trial is officially happening. But before the FDA cleared it, Harvard professor David Sinclair had to pull off a mice experiment most scientists thought was impossible: "These mice had their optic nerve regenerated. We were able to...

By John Cumbers
NY AI Ban Shields Cartel, Ignoring Uninsured Crisis
SocialMar 14, 2026

NY AI Ban Shields Cartel, Ignoring Uninsured Crisis

New York wants to ban AI that outscores doctors on medical exams. Over 900,000 New Yorkers have no insurance. 92% of low-income legal problems go unaddressed. Anti-AI NY bill S7263 isn't consumer protection. It's cartel protection. https://t.co/e9BdWuvvUB

By Garry Tan
AI Sleep Model Predicts 130+ Diseases From PSG
SocialMar 14, 2026

AI Sleep Model Predicts 130+ Diseases From PSG

SleepFM is a multimodal #AI foundation model for disease prediction. Developed by @Stanford researchers, trained on over 585K hours of polysomnography (PSG) data from 65K patients. It analyzes brain, heart, & respiratory signals to predict 130+ diseases—including dementia, cancer, and heart...

By Daniel Kraft, MD
Exploring Tomorrow's Medicine with Global Leaders at ATOM
SocialMar 14, 2026

Exploring Tomorrow's Medicine with Global Leaders at ATOM

So proud to be on stage again with Serena at the ATOM event in LA talking to our dear friends Vartan Sarkissian and his father President Armen Sarkissian of Armenia 🇦🇲 about the future of medicine and healthcare 🧬 ATOM...

By David Sinclair
One in Six on Hospital Waiting List Amid Record Taxes
SocialMar 13, 2026

One in Six on Hospital Waiting List Amid Record Taxes

Wait? How is this possible. That would be 1 in 6 people are on a hospital waiting list? It's criminal how bad this countries health service is given we've had record tax income.

By Kieran Flanagan
Vaccination Boosts Survival in Multiple Myeloma Patients
SocialMar 13, 2026

Vaccination Boosts Survival in Multiple Myeloma Patients

Rates of Influenza and Pneumococcal Vaccination and Correlation with Survival in Multiple Myeloma Patients [Dec 6, 2022] @mtmdphd et al. @AjaiChari CLML https://t.co/kUQeRmdKWV #NCT02761187 #mmsm #IDonc #ClinicalTrials #caxtx https://t.co/L7r9caCcGN

By Mike Thompson, MD PhD
Navigating Myeloma MRD: Risks, Benefits, and Treatment Decisions
SocialMar 13, 2026

Navigating Myeloma MRD: Risks, Benefits, and Treatment Decisions

MT @hhashmi87 #IMS25 Great Meet The Expert talk by @bdermanmd on MRD in Myeloma Risk vs benefit Who can stop treatment Active surveillance post discontinuation #mmMRD #mmsm https://t.co/YOBOPs7hQL

By Mike Thompson, MD PhD
MRD‑Negative Patients May Stop Myeloma Maintenance Therapy
SocialMar 13, 2026

MRD‑Negative Patients May Stop Myeloma Maintenance Therapy

Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP) - @bdermanmd et al. @ajjakubowiak #ASCO24 Abstract 106 https://t.co/FBTY7SnCxK #NCT04108624 #mmsm #mmMRD

By Mike Thompson, MD PhD
Clinicians Show Mixed Adoption of MRD in Myeloma
SocialMar 13, 2026

Clinicians Show Mixed Adoption of MRD in Myeloma

Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] @bdermanmd @jagoda_jasielec @ajjakubowiak Brit J Haematol https://t.co/8zhxYfYwZQ #mmsm #mmMRD https://t.co/QTlR2gv5Q0

By Mike Thompson, MD PhD
Understanding MRD's Role in Multiple Myeloma Management
SocialMar 13, 2026

Understanding MRD's Role in Multiple Myeloma Management

#mmMRD healthcare social media hashtag [Nov 21, 2020] Minimal/measurable residual disease (MRD) in multiple myeloma. Submitted by @bdermanmd to @symplur @healthhashtags https://t.co/grkkiox2yh #mmsm No longer available at Symplur https://t.co/IGDrNALHBP

By Mike Thompson, MD PhD
Coffee and Tea Linked to Reduced Neurodegenerative Disease Risk
SocialMar 13, 2026

Coffee and Tea Linked to Reduced Neurodegenerative Disease Risk

Consumption of coffee and tea and the risk of developing neurodegenerative diseases: a cohort study in the UK biobank https://t.co/bv0q79xKni

By Michael Lustgarten, PhD
VR Lets Hospital Patients Explore Beauty Beyond Walls
SocialMar 13, 2026

VR Lets Hospital Patients Explore Beauty Beyond Walls

A hospital room can feel very small. But the mind doesn’t have to stay there. At Cedars-Sinai, we’re using VR to help patients explore beautiful places beyond the four walls of the hospital room. Not to escape life… but to contemplate its beauty in...

By Brennan Spiegel, MD
Embrace Telehealth Early or Lose Clients Forever
SocialMar 13, 2026

Embrace Telehealth Early or Lose Clients Forever

Six years ago today, on Friday, March 13, 2020, I sent the email switching all my clients to telehealth. Some of them didn’t want to do online sessions; they said they’d rather wait a little, until things blew over. I...

By Riva | A Therapist Can’t Say That
AI to Autonomously Report X‑Rays Within Five Years
SocialMar 13, 2026

AI to Autonomously Report X‑Rays Within Five Years

AI will likely report most X-rays near-autonomously within 3–5 years. We may soon have AI generating reports instantly… while radiologists still wait for the RIS loading wheel to open them.

By Amine Korchi, MD
SF Drug Crisis Stymied by Laws Banning Proven Solutions
SocialMar 13, 2026

SF Drug Crisis Stymied by Laws Banning Proven Solutions

Research SF’s drug crisis is like trying to fight a fire and finding out a bunch of laws passed that make using water to fight fires illegal. Then having to research non-water based solutions to large scale fires.

By Michael Seibel
Shift to Proactive Planning Boosts MedTech Margins
SocialMar 13, 2026

Shift to Proactive Planning Boosts MedTech Margins

New MPO article by Lisa Anderson: From Reactive to Proactive: planning strategies for Medtech customer and margin success. Ready to move from firefighting to proactive planning? Contact LMA. #MedTech #SIOP #SupplyChain https://t.co/6Kr0hpMRaq

By Lisa Anderson
Robotic Surgery Expands Into AI-Enhanced Precision
SocialMar 13, 2026

Robotic Surgery Expands Into AI-Enhanced Precision

Robots’ potentials have been a fascination for humans and have even led to a booming field of robot-assisted surgery. Surgical robots assist surgeons in performing accurate, minimally invasive procedures that are beneficial for patients’ recovery. The assistance of robots extend beyond incisions...

By Bertalan Meskó, PhD
Aging Outpaces Medicine in Cancer Risk Race
SocialMar 13, 2026

Aging Outpaces Medicine in Cancer Risk Race

The longer we live, the more the cancer odds go against us. So it is a race between medicine and aging. More on this in the Chartbook Top Links today. https://t.co/RpUy2t9fij

By Adam Tooze
Epic’s MyChart Fragments Records, Hindering True Interoperability
SocialMar 13, 2026

Epic’s MyChart Fragments Records, Hindering True Interoperability

Class-action lawsuit claims Epic’s MyChart fragments patient records across portals, blocking full access & delaying disability claims. True interoperability still a challenge in digital health. https://t.co/jiKal8ggTl #DigitalHealth

By Paul Sonnier
CMS Delays Florida Direct Payment Approval for UHS
SocialMar 13, 2026

CMS Delays Florida Direct Payment Approval for UHS

HEARING $UHS --negative call out right now- CMS has delayed Florida Direct payment approval due to CMS concerns-- capital forum confirmed

By Mark Lehman (MarkFlowChatter)
Epigenetic Therapy Marks New Era in Glaucoma Treatment
SocialMar 13, 2026

Epigenetic Therapy Marks New Era in Glaucoma Treatment

Great to see ophthlamologists adopting epigenetic modifications and resets to treat eye diseases like glaucoma. A paradigm shift in medicine https://t.co/g2gr3WVpkf https://t.co/6gbBVHJuXI

By David Sinclair, PhD
Congress Urges Curb on Costly Medicare Advantage Subsidies
SocialMar 13, 2026

Congress Urges Curb on Costly Medicare Advantage Subsidies

Congressional advisers call to rein in Medicare Advantage spending amid industry pressure I’ll summarize for you. EVERY SINGLE FAMILY IN THE USA IS PAYING $800 A YEAR to the big insurance companies because taxpayers pay them more than it...

By Mark Cuban
Midlife Joint Pain Signals Systemic Decline, Not Isolated Injury
SocialMar 13, 2026

Midlife Joint Pain Signals Systemic Decline, Not Isolated Injury

I’ve been an orthopedic surgeon for nearly 30 years, and a few patterns have become impossible to ignore. One is that many musculoskeletal problems in adults aren’t sudden injuries. They’re the moment when declining capacity and awful metabolic health finally...

By Howard Luks, MD
China Biotech Receives FDA Approval for First Cell Therapy Trial
SocialMar 13, 2026

China Biotech Receives FDA Approval for First Cell Therapy Trial

With FDA go ahead, a China #biotech notches a first in cell therapy testing https://t.co/QorwJmou8w by @realJacobBell $XENE $BHVN

By Ben Fidler
Measles Cases Surge: 92% Unvaccinated, 60% of Last Year
SocialMar 13, 2026

Measles Cases Surge: 92% Unvaccinated, 60% of Last Year

1. #Measles update: The total confirmed cases so far this year has risen to 1362 as of 3/12. Key context: The 2026 total to date is 60% of the 2025 total for the entire year. #CDC reports that among cases with...

By Helen Branswell
Cancer Vaccines Show Promise for Hard-to-Treat Tumors
SocialMar 13, 2026

Cancer Vaccines Show Promise for Hard-to-Treat Tumors

Cancer vaccines are showing marked efficacy vs refractory cancers and are going to be part of the future Rx armamentarium. Beyond that, ultimately, for prevention in high-risk individuals. A new stellar review @NatureMedicine https://t.co/PhtdZDtSBl https://t.co/okmwCD8AyB

By Eric Topol
Clinician Trust, Not Dashboards, Drives Sustainable Improvement
SocialMar 13, 2026

Clinician Trust, Not Dashboards, Drives Sustainable Improvement

Lasting improvement doesn’t come from dashboards or mandates. It comes from clinicians who trust the data and own the change. A great conversation on what really works. 👉 https://t.co/SwV5qc59SV @HealthCatalyst #clinicalimprovement #HITSM

By Colin Hung
Adults' Diagnosis Denial Won’t Aid Children’s Care
SocialMar 13, 2026

Adults' Diagnosis Denial Won’t Aid Children’s Care

It is not clear to me how denying diagnosis to adults like me would get children more medical help.

By Frances Coppola
Amyloid Antibody Therapy Triggers 100 Microhemorrhages in APOE4 Patient
SocialMar 13, 2026

Amyloid Antibody Therapy Triggers 100 Microhemorrhages in APOE4 Patient

100 brain microhemorrhages in a patient with cerebral amyloid angiopathy and 2 copies of APOE4 after amyloid antibody therapy https://t.co/ASpVuijFNW https://t.co/hdtwtv1usq

By Eric Topol
LAG‑3 Checkpoint Suffers Another Trial Setback, Focus Shifts
SocialMar 13, 2026

LAG‑3 Checkpoint Suffers Another Trial Setback, Focus Shifts

NEW: Another failure in the clinic in the world of LAG-3, a target once seen as possibly the next major checkpoint inhibitor after PD-1 and CTLA-4. My latest on Immutep's Phase 3 disappointment, as LAG-3 focus now shifts to a...

By Andrew Dunn
Seeking NHS Waiting List Insights for Upcoming Piece
SocialMar 13, 2026

Seeking NHS Waiting List Insights for Upcoming Piece

@angelazhay - I'd be keen to make contact with you to discuss NHS waiting lists for a piece I'm working on. Could you reach me on laura.donnelly@telegraph.co.uk?

By Laura Donnelly
De Novo Enzymes Redefine Peptide Therapeutic Production
SocialMar 13, 2026

De Novo Enzymes Redefine Peptide Therapeutic Production

Peptide therapeutics are powerful. But making them has always been difficult. Traditional chemical synthesis can involve long routes, poor selectivity, and significant environmental impact, while biological production is often limited by the pathways evolution happened to provide. What if we could design...

By John Cumbers
HSV-1 Reactivation Linked to Faster Aging, Dementia
SocialMar 13, 2026

HSV-1 Reactivation Linked to Faster Aging, Dementia

The reactivation of herpes simplex virus (HSV-1, not only herpes zoster) may be tied to accelerated aging and dementia, and account in part for the mechanism of Shingrix vaccine''s protection @WIRED https://t.co/iKF1JcYSu0

By Eric Topol
Biotech Layoffs Hit Evotec, Vistagen; Immutep Shares Plunge
SocialMar 13, 2026

Biotech Layoffs Hit Evotec, Vistagen; Immutep Shares Plunge

Evotec, Vistagen lay off staff; Immutep shares collapse on study failure https://t.co/OikmCdJ6sg $EVO $VTGN $IMMP - 81% $RARE $ATRA

By Ben Fidler
Patients Should Drive Aggressive Immunotherapy Post-Remission
SocialMar 13, 2026

Patients Should Drive Aggressive Immunotherapy Post-Remission

Merkel cell carcinoma log, day #594. Yesterday, I was at Dana-Farber for my first infusion of avelumab in more than 3 months. Aside from two botched blood tests — the buzz is the blood tests are being done with recently...

By John Carroll
New Drug May Replace CPAP for Sleep Apnea‑Heart Risk
SocialMar 13, 2026

New Drug May Replace CPAP for Sleep Apnea‑Heart Risk

On @fox5ny with @stevelacy and natashacurrytv discussing the very real connection between sleep apnea and heart disease. There may be a drug therapy on the horizon to free us of the clap machine. @helloheartapp @morehouseschoolofmedicine mag1849_ medical_association_of_atlanta

By Jayne Morgan, MD
White House Declares Vaccine Debate over, Eyes MAGA‑MAHA Alliance
SocialMar 13, 2026

White House Declares Vaccine Debate over, Eyes MAGA‑MAHA Alliance

“We’re just kind of done with the vaccine issue,” said one White House official. “We’ve done what we want to do on the vaccine front.” On the future of the MAGA-MAHA alliance, w/ @ChelseaCirruzzo https://t.co/g6goE2TC6e

By Daniel Payne
5‑Minute Calcium Scan Beats Cholesterol for Heart Risk
SocialMar 13, 2026

5‑Minute Calcium Scan Beats Cholesterol for Heart Risk

The Coronary Artery Calcium Scan - The Heart Disease Test You've Never Heard Of There's a 5-minute heart scan… No needles. No treadmill. No contrast dye. And it predicts heart attack risk better than cholesterol alone. https://youtu.be/XVNLubDAE-M

By Robert Lufkin, MD
White House Must Nominate CDC Director by March 25
SocialMar 13, 2026

White House Must Nominate CDC Director by March 25

On the clock: The White House has until 3/25 to nominate a new #CDC director. The Federal Vacancies Reform Act states a job like CDC director can only be filled on an acting basis for 210 days from the creation...

By Helen Branswell
Healthcare Spending Jumps 7.9%—Outpacing Inflation
SocialMar 13, 2026

Healthcare Spending Jumps 7.9%—Outpacing Inflation

Spending on healthcare services is up 7.9% year over year, far higher than the inflation rate reported in the CPI https://t.co/Mt0STaWkJz

By Dean Baker